1. Home
  2. CING vs AIEV Comparison

CING vs AIEV Comparison

Compare CING & AIEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • AIEV
  • Stock Information
  • Founded
  • CING 2012
  • AIEV 2011
  • Country
  • CING United States
  • AIEV United States
  • Employees
  • CING N/A
  • AIEV N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • AIEV Blank Checks
  • Sector
  • CING Health Care
  • AIEV Finance
  • Exchange
  • CING Nasdaq
  • AIEV Nasdaq
  • Market Cap
  • CING 14.4M
  • AIEV 11.6M
  • IPO Year
  • CING 2021
  • AIEV N/A
  • Fundamental
  • Price
  • CING $4.27
  • AIEV $0.24
  • Analyst Decision
  • CING Strong Buy
  • AIEV
  • Analyst Count
  • CING 3
  • AIEV 0
  • Target Price
  • CING $16.00
  • AIEV N/A
  • AVG Volume (30 Days)
  • CING 118.1K
  • AIEV 175.4K
  • Earning Date
  • CING 03-31-2025
  • AIEV 03-07-2025
  • Dividend Yield
  • CING N/A
  • AIEV N/A
  • EPS Growth
  • CING N/A
  • AIEV N/A
  • EPS
  • CING N/A
  • AIEV N/A
  • Revenue
  • CING N/A
  • AIEV N/A
  • Revenue This Year
  • CING N/A
  • AIEV N/A
  • Revenue Next Year
  • CING N/A
  • AIEV N/A
  • P/E Ratio
  • CING N/A
  • AIEV N/A
  • Revenue Growth
  • CING N/A
  • AIEV N/A
  • 52 Week Low
  • CING $1.80
  • AIEV $0.22
  • 52 Week High
  • CING $20.83
  • AIEV $12.12
  • Technical
  • Relative Strength Index (RSI)
  • CING 42.05
  • AIEV N/A
  • Support Level
  • CING $4.22
  • AIEV N/A
  • Resistance Level
  • CING $4.58
  • AIEV N/A
  • Average True Range (ATR)
  • CING 0.32
  • AIEV 0.00
  • MACD
  • CING -0.04
  • AIEV 0.00
  • Stochastic Oscillator
  • CING 12.64
  • AIEV 0.00

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About AIEV Thunder Power Holdings Inc. Common Stock

Thunder Power Holdings Inc is engaged in the design and development of high-performance electric vehicles.

Share on Social Networks: